Gracias por visitar nuestro sitio web.
Hasta nuevo aviso, Plusmarkets.eu no acepta nuevos clientes.
PlusMarkets Analysis • 14/10/2021
The Market data was collected on 14 October 2021 at 09:15, and might have changed since then. Kindly refer to the listed sources for the most recent and updated information.
J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study
People who got Johnson & Johnson (NYSE:JNJ) Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer (NYSE:PFE) Inc/BioNTech SE or Moderna (NASDAQ:MRNA) Inc, a study run by the National Institutes of Health showed on Wednesday.
The study, which is preliminary and hasn’t been peer reviewed, is the latest challenge to J&J’s efforts to use its COVID-19 vaccine as a booster in the United States.
The study, which included more than 450 adults who received initial shots from Pfizer, Moderna, or Johnson & Johnson, showed that «mixing and matching» booster shots of different types is safe in adults. Moderna’s and Pfizer’s vaccines are based on messenger RNA while J&J’s uses viral vector technology.
It comes as an advisory group to the U.S. Food and Drug Administration is preparing to meet later this week to discuss the merits of a booster shot for Moderna and J&J vaccines.
FDA officials on Wednesday said J&J’s regulatory submission for its planned booster raised red flags including small sample sizes and data based on tests that had not been validated.
Dollar pauses after rally to one-year high; Aussie, kiwi rebound
The U.S. dollar touched its lowest point this week against major peers on Thursday, taking a breather from a rally that had lifted it to a one-year high powered by expectations for quicker Federal Reserve interest rate hikes.
The Australian and New Zealand dollars reached multi-week highs, while cryptocurrency bitcoin rose to a five-month peak.
The dollar index, which measures the greenback against six rivals, was about flat at 94.048, after dropping 0.53% on Wednesday, the most since Aug. 23.
The index reached 94.563 on Tuesday, its highest since late September 2020, after surging nearly 3% since early last month.
The dollar pulled back even after minutes of the Federal Open Market Committee’s September meeting confirmed tapering of stimulus is all but certain to start this year, and showed a growing number of policymakers worried that high inflation could persist.
A Labor Department report showed U.S. consumer prices rose solidly in September, and they are likely to rise further amid a surge in energy prices, potentially pressuring the Fed to act sooner to normalise policy.
Oil rises on bigger-than-expected draw in U.S. fuel stocks
Oil prices climbed on Thursday, reversing previous losses, as a bigger-than-expected draw in U.S. gasoline and distillate stocks prompted buying.
Prices were also buoyed by expectations that soaring natural gas prices as winter approaches will drive a switch to oil to meet heating demand.
Brent crude futures gained 52 cents, or 0.6%, to $83.70 a barrel at 0330 GMT after falling 0.3% on Wednesday.
U.S. West Texas Intermediate (WTI) crude futures climbed 52 cents, or 0.7%, to $80.96 a barrel, after dropping 0.3% the previous day.
«A larger-than-expected drop in the U.S. gasoline and distillate inventories led to fresh buying,» said Kazuhiko Saito, chief analyst at Fujitomi Securities Co Ltd.
The American Petroleum Institute (API) said on Wednesday U.S. crude stockpiles rose by 5.2 million barrels for the week ended Oct. 8, but gasoline inventories fell by 4.6 million barrels and distillate stocks fell by 2.7 million barrels, according to market sources who saw the API data.
Legal disclaimer: The material does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instruments. UR Trade Fix Ltd accepts no responsibility for any use that may be made of these comments and for any consequences resulting in it. No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. The analysis does not involve any specific investment objectives, financial situation and needs of any specific person who may receive it. Past performance does not constitute a reliable indicator of future results and future forecasts do not constitute a reliable indicator of future performance.
It has not been prepared in accordance with legal requirements designed to promote the independence of research, and as such it is considered to be marketing communication. Although we are not specifically constrained from dealing ahead of the publication of our research, we do not seek to take advantage of it before we provide it to our clients. We aim to establish, maintain and operate effective organizational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients. We operate a policy of independence, which requires our employees to act in our clients’ best interests when providing our services